Page 53 - 2019
P. 53

drives collaboration and when lack of trust impedes collaboration? Moreover, does the
          trust  factor  impact  any  of  the  other  factors  that  determine  collaboration  formation  by
          SMEs?  The  current  study  aims  to  investigate  answers  to  these  questions  through  an
          empirical research methodology.

          The study began with a set of variables taken from literature review and addition of new
          variables derived from expert interviews of four pharmaceutical SME owners. This was
          followed by descriptive research with a sample of 174 SMEs of pharmaceutical sector of
          Gujarat. The responses were collected through questionnaire. Exploratory Factor Analysis
          was conducted to identify motives of collaboration in SMEs. Next, one-sample t-test was
          conducted to assess enablers and inhibitors of collaboration in SMEs. This was followed
          by  ANOVA  to  study  the  nature  of  enablers  and  inhibitors  across  the  different
          pharmaceutical clusters. Next, simple regression was used to assess if and how motives
          of collaboration impact the enablers and inhibitors of collaboration.

          Further, the composition of trust was investigated using Exploratory Factor Analysis. The
          profiles  of  trust  playing  the  role  of  an  enabler  and  lack  of  trust  playing  the  role  of  an
          inhibitor  were  identified  through  Discriminant  Analysis,  followed  by  Regression.  Next,
          Hierarchical Multiple Regression Analysis was conducted to assess whether composite
          trust  moderates  the  other  enablers  and  inhibitors.  Lastly,  ANOVA  was  conducted  to
          compare the firmographic variables across clusters.
          The study finds that SMEs of pharmaceutical industry, concentrated in four city-based
          clusters of Gujarat, have mixed motives of collaboration ranging from amongst others,
          pursuit of Innovation on one hand to Cost and Risk Reduction on the other. Therefore, as
          some  studies  discuss  the  broad  ranging  motives  of  collaboration,  the  current  study
          advances  the  knowledge  in  the  context  of  Indian  SMEs.  Moreover,  SMEs  of
          pharmaceutical sector are found to have presence of trust; geographic proximity; power
          balance;  large  partner  size  and  strategic  similarities  as  important  enablers  of
          collaboration. On the other hand, the study reveals that SMEs face collaboration inhibitors
          in  the  form  of  lack  of  trust;  power  imbalance;  uncertainty  related  to  collaboration;
          resource inadequacy; smaller partner size; strategic dissimilarities; legitimacy of partner
          firm  and  difference  in  risk  acceptance  levels.  This  insight  corroborates  with  extant
          literature and advances the body of knowledge with SME context. Additionally, the study
          demonstrates that size of an industry cluster in terms of number of firms has no impact
          on the nature of enablers and inhibitors. In simpler terms, factors impacting collaboration
          are industry specific and are not influenced by size of an industry cluster. This insight is
          an addition to extant studies on collaboration in SMEs.

          The  study  also  reveals  that  out  of  the  four  motives  identified,  Innovation  and  Strategy

                                                                                             34
   48   49   50   51   52   53   54   55   56   57   58